|
Human Gene Therapy
Transglutaminase 1 Delivery to Lamellar Ichthyosis Keratinocytes
To cite this article:
Keith A. Choate, Todd M. Kinsella, Mary L. Williams, Garry P. Nolan, Paul A. Khavari.
Human Gene Therapy.
December 1996,
7(18): 2247-2253.
doi:10.1089/hum.1996.7.18-2247.
Keith A. Choate1,2 Todd M. Kinsella3 Mary L. Williams4 Garry P. Nolan3 Address reprint requests to: Dr. Paul A. Khavari, Chief, Dermatology Service [123], Palo Alto V.A. Medical Center, 3801 Miranda Ave, Palo Alto, CA 94304 03 07 1996 Received for publication July 3, 1996. 18 09 1996 Accepted after revision September 18, 1996. ABSTRACT Therapeutic gene delivery in severe genetic skin disease may require production of a uniformly corrected population of cells capable of regeneration of normal skin elements when returned to the host. To achieve this, we have used lamellar ichthyosis (LI), a disorder of epidermal differentiation recently associated with defects in keratinocyte transglutaminase (TGase1), as a prototype. We have used a high-efficiency retroviral delivery approach to uniformly restore normal levels of TGase1 expression to primary keratinocytes from severely affected LI patients previously lacking TGase1. Delivered TGase1 was correctly targeted to membrane association and restored patient cell transglutaminase activity levels to normal. Corrected primary LI patient keratinocytes also demonstrated restoration of previously defective involucrin cross-linking and in vitro measures of cornification to levels found in normal cells. These results indicate that efficient TGase1 delivery to early passage keratinocytes can produce a population of corrected LI patient cells. The capability to produce such cells may provide a basis for future efforts at gene therapy for genetic skin disease. Overview summary Production and characterization of uniformly corrected primary cells in vitro suitable for therapeutic return to patients with monogenic diseases can pose a significant challenge. The recently characterized transglutaminase 1 (TGase1)-deficient disorder, lamellar ichthyosis (LI), offers a prototype for development of this capability using keratinocytes from patients with this severe genetic skin disease. We show here that primary cells from LI patient skin can be rapidly engineered at high efficiency and without subsequent selection via a retroviral expression vector for TGase1. It is shown that this gene delivery restores measures of cellular functions to normal. This rapid and high-efficiency approach for corrective gene delivery to primary patient cells in vitro may serve as a model for efforts in the skin and other tissues.  This paper was cited by:Molecular genetics of the ichthyoses Gabriele Richard American Journal of Medical Genetics. Dec 2004, Vol. 131C, No. 1: 32-44 CrossRef Gene transfer to epidermal stem cells: implications for tissue engineering Stelios T Andreadis Expert Opinion on Biological Therapy. Jul 2004, Vol. 4, No. 6: 783-800 CrossRef Development of spliceosome-mediated RNA trans-splicing (SMaRTtm) for the correction of inherited skin diseases G. Dallinger, M. Puttaraju, L. G. Mitchell, K. B. Yancey, C. Yee, A. Klausegger, H. Hintner, J. W. Bauer Experimental Dermatology. Mar 2003, Vol. 12, No. 1: 37-46 CrossRef Retroviral Gene Transfer to Human Epidermal Keratinocytes Correlates with Integrin Expression and Is Significantly Enhanced on Fibronectin Bharat Bajaj, Shahram Behshad, Stelios T. Andreadis Human Gene Therapy. Oct 2002, Vol. 13, No. 15: 1821-1831 Abstract | Full Text PDF | Reprints & PermissionsAnimal Models for Skin Blistering Conditions: Absence of Laminin 5 Causes Hereditary Junctional Mechanobullous Disease in the Belgian Horse Flavia Spirito, Alexandra Charlesworth, Keith Linder, Jean-Paul Ortonne, John Baird, Guerrino Meneguzzi Journal of Investigative Dermatology. Oct 2002, Vol. 119, No. 3: 684-691 CrossRef Membrane Type 1 Matrix Metalloproteinase Regulates Cellular Invasiveness and Survival in Cutaneous Epidermal Cells Usha Nagavarapu, Kenneth Relloma, G. Scott Herron Journal of Investigative Dermatology. May 2002, Vol. 118, No. 4: 573-581 CrossRef Sustainable Systemic Delivery via a Single Injection of Lentivirus into Human Skin Tissue Seung-Cheol Baek, Qun Lin, Paul B. Robbins, Hongran Fan, Paul A. Khavari Human Gene Therapy. Aug 2001, Vol. 12, No. 12: 1551-1558 Abstract | Full Text PDF | Reprints & PermissionsImpact of Laminin 5 β3 Gene versus Protein Replacement on Gene Expression Patterns in Junctional Epidermolysis Bullosa Paul B. Robbins, Shannon M. Sheu, Julia B. Goodnough, Paul A. Khavari Human Gene Therapy. Jul 2001, Vol. 12, No. 11: 1443-1448 Abstract | Full Text PDF | Reprints & PermissionsCutaneous gene transfer and therapy: the present and the future Flavia Spirito, Guerrino Meneguzzi, Olivier Danos, Mauro Mezzina The Journal of Gene Medicine. Feb 2001, Vol. 3, No. 1: 21-31 CrossRef Genetic Correction of Inherited Epidermal Disorders Paul A. Khavari Human Gene Therapy. Nov 2000, Vol. 11, No. 16: 2277-2282 Abstract | Full Text PDF | Reprints & PermissionsCultivation of human keratinocyte stem cells: current and future clinical applications G. Pellegrini, S. Bondanza, L. Guerra, M. Luca Medical & Biological Engineering & Computing. Dec 1998, Vol. 36, No. 6: 778-790 CrossRef Sustainable cutaneous gene delivery Helen Deng, Qun Lin, Paul A. Khavari Nature Biotechnology. Jan 1998, Vol. 15, No. 13: 1388-1391 CrossRef Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog Hongran Fan, Anthony E. Oro, Matthew P. Scott, Paul A. Khavari Nature Medicine. Aug 1997, Vol. 3, No. 7: 788-792 CrossRef
|
|